STOCK TITAN

[S-8] Luminar Technologies, Inc. Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8
Rhea-AI Filing Summary

On 25-Jul-2025 EQT Corp EVP Upstream Sarah Fenton filed a Form 4 disclosing two transactions. She sold 12,438 common shares at a weighted-average $51.94–$51.95, generating roughly $0.65 million in proceeds. The same day she received 26,620 restricted stock units (RSUs) that will convert one-for-one into EQT stock, vesting in three equal annual tranches beginning one year from grant. After the sale and grant, her direct beneficial ownership increased to 39,917 shares, a net rise of 14,182 shares (≈55 %). The share-sale footnote states full price breakdowns are available on request and that totals include accrued dividends. No derivative securities, options or other instruments were reported. While insider selling can be viewed negatively, the concurrent, larger RSU award results in an overall increase in ownership, tempering signalling concerns. The filing contains no company-level financial or strategic updates.

Il 25 luglio 2025 Sarah Fenton, EVP Upstream di EQT Corp, ha presentato un Modulo 4 dichiarando due operazioni. Ha venduto 12.438 azioni ordinarie a un prezzo medio ponderato di 51,94–51,95 dollari, generando circa 0,65 milioni di dollari di ricavi. Nello stesso giorno ha ricevuto 26.620 unità di azioni vincolate (RSU) che si convertiranno in azioni EQT uno a uno, con maturazione in tre tranche annuali uguali a partire da un anno dalla concessione. Dopo la vendita e la concessione, la sua proprietà diretta è aumentata a 39.917 azioni, con un incremento netto di 14.182 azioni (circa il 55%). La nota sulla vendita delle azioni indica che le suddivisioni dettagliate dei prezzi sono disponibili su richiesta e che i totali includono i dividendi maturati. Non sono stati segnalati titoli derivati, opzioni o altri strumenti. Sebbene la vendita da parte di un insider possa essere interpretata negativamente, l’assegnazione contemporanea e più consistente di RSU comporta un aumento complessivo della proprietà, attenuando così eventuali preoccupazioni di segnalazione. La documentazione non contiene aggiornamenti finanziari o strategici a livello aziendale.

El 25 de julio de 2025, Sarah Fenton, EVP Upstream de EQT Corp, presentó un Formulario 4 revelando dos transacciones. Ella vendió 12,438 acciones comunes a un precio promedio ponderado de 51,94–51,95 dólares, generando aproximadamente 0,65 millones de dólares en ingresos. Ese mismo día recibió 26,620 unidades restringidas de acciones (RSU) que se convertirán una a una en acciones de EQT, con un periodo de adquisición en tres partes iguales anuales a partir de un año después de la concesión. Tras la venta y la concesión, su propiedad directa aumentó a 39,917 acciones, un incremento neto de 14,182 acciones (aproximadamente 55%). La nota sobre la venta de acciones indica que los desgloses completos de precios están disponibles a solicitud y que los totales incluyen dividendos acumulados. No se reportaron valores derivados, opciones u otros instrumentos. Aunque la venta por parte de un insider puede verse negativamente, el premio simultáneo y mayor de RSU resulta en un aumento general en la propiedad, mitigando preocupaciones sobre señales. La presentación no contiene actualizaciones financieras o estratégicas a nivel de la empresa.

2025년 7월 25일, EQT Corp의 EVP Upstream인 Sarah Fenton은 두 건의 거래를 공개하는 Form 4를 제출했습니다. 그녀는 12,438주의 보통주를 가중평균 가격 $51.94–$51.95에 매도하여 약 65만 달러의 수익을 창출했습니다. 같은 날 그녀는 26,620개의 제한 주식 단위(RSU)를 받았으며, 이는 1대1로 EQT 주식으로 전환되며, 1년 후부터 3년에 걸쳐 동일한 비율로 권리가 부여됩니다. 매도와 수령 이후 그녀의 직접 보유 주식은 39,917주로 증가하여 순증가분은 14,182주(약 55%)입니다. 주식 매도 주석에는 가격 세부 내역이 요청 시 제공되며, 총액에는 누적 배당금이 포함되어 있다고 명시되어 있습니다. 파생 증권, 옵션 또는 기타 금융 상품은 보고되지 않았습니다. 내부자의 매도는 부정적으로 해석될 수 있으나, 동시에 이루어진 더 큰 RSU 수령으로 전체 보유 지분이 증가해 신호에 대한 우려를 완화합니다. 제출 문서에는 회사 차원의 재무 또는 전략적 업데이트는 포함되어 있지 않습니다.

Le 25 juillet 2025, Sarah Fenton, EVP Upstream d'EQT Corp, a déposé un formulaire 4 dévoilant deux transactions. Elle a vendu 12 438 actions ordinaires à un prix moyen pondéré de 51,94–51,95 dollars, générant environ 0,65 million de dollars de produit. Le même jour, elle a reçu 26 620 unités d'actions restreintes (RSU) qui se convertiront en actions EQT à raison d'une pour une, avec une acquisition en trois tranches annuelles égales commençant un an après l'attribution. Après la vente et l'attribution, sa détention directe a augmenté à 39 917 actions, soit une hausse nette de 14 182 actions (environ 55 %). La note de bas de page sur la vente d'actions indique que des détails complets sur les prix sont disponibles sur demande et que les totaux incluent les dividendes accumulés. Aucun titre dérivé, option ou autre instrument n'a été déclaré. Bien que la vente par un initié puisse être perçue négativement, l'attribution simultanée et plus importante de RSU entraîne une augmentation globale de la participation, atténuant ainsi les inquiétudes liées au signal. Le dépôt ne contient aucune mise à jour financière ou stratégique au niveau de l'entreprise.

Am 25. Juli 2025 reichte Sarah Fenton, EVP Upstream von EQT Corp, ein Formular 4 ein, das zwei Transaktionen offenlegt. Sie verkaufte 12.438 Stammaktien zu einem gewichteten Durchschnittspreis von 51,94–51,95 USD und erzielte damit rund 0,65 Millionen USD Erlös. Am selben Tag erhielt sie 26.620 Restricted Stock Units (RSUs), die eins zu eins in EQT-Aktien umgewandelt werden und in drei gleichen jährlichen Tranchen ab einem Jahr nach der Gewährung vesten. Nach Verkauf und Gewährung stieg ihr direkter Besitz auf 39.917 Aktien, ein Nettostieg von 14.182 Aktien (ca. 55 %). Die Fußnote zum Aktienverkauf weist darauf hin, dass vollständige Preisaufschlüsselungen auf Anfrage verfügbar sind und dass die Gesamtzahlen aufgelaufene Dividenden enthalten. Es wurden keine Derivate, Optionen oder andere Instrumente gemeldet. Obwohl Insider-Verkäufe negativ gesehen werden können, führt die gleichzeitig größere RSU-Zuteilung zu einer Gesamtsteigerung des Besitzes, was Signalisierungsbedenken mildert. Die Einreichung enthält keine finanzielle oder strategische Unternehmensaktualisierung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Net ownership rises 55 % despite $0.65 m sale; signalling impact likely neutral.

The 12,438-share sale appears to be routine liquidity or tax-planning given its small absolute size versus EQT’s 424 m share base. More importantly, the 26,620-unit RSU grant lifts Fenton’s stake to 39,917 shares, increasing alignment with shareholders. Because the RSUs vest over three years, they incentivise long-term performance and partially offset the negative optics of an open-market sale. I view the overall impact on sentiment as neutral; no implications for EQT’s fundamentals emerge from this filing.

TL;DR: Mixed insider signal—sale offset by larger time-vested equity grant.

Insider sales often trigger governance red flags, but context matters. The reported disposal equals just 31 % of Fenton’s pre-transaction holdings and coincides with a compensatory RSU award that expands her economic exposure. The staggered vesting schedule discourages short-termism. No other executives were party to the filing, suggesting an isolated event rather than a coordinated sell-down. I classify the disclosure as not impactful for governance risk assessments.

Il 25 luglio 2025 Sarah Fenton, EVP Upstream di EQT Corp, ha presentato un Modulo 4 dichiarando due operazioni. Ha venduto 12.438 azioni ordinarie a un prezzo medio ponderato di 51,94–51,95 dollari, generando circa 0,65 milioni di dollari di ricavi. Nello stesso giorno ha ricevuto 26.620 unità di azioni vincolate (RSU) che si convertiranno in azioni EQT uno a uno, con maturazione in tre tranche annuali uguali a partire da un anno dalla concessione. Dopo la vendita e la concessione, la sua proprietà diretta è aumentata a 39.917 azioni, con un incremento netto di 14.182 azioni (circa il 55%). La nota sulla vendita delle azioni indica che le suddivisioni dettagliate dei prezzi sono disponibili su richiesta e che i totali includono i dividendi maturati. Non sono stati segnalati titoli derivati, opzioni o altri strumenti. Sebbene la vendita da parte di un insider possa essere interpretata negativamente, l’assegnazione contemporanea e più consistente di RSU comporta un aumento complessivo della proprietà, attenuando così eventuali preoccupazioni di segnalazione. La documentazione non contiene aggiornamenti finanziari o strategici a livello aziendale.

El 25 de julio de 2025, Sarah Fenton, EVP Upstream de EQT Corp, presentó un Formulario 4 revelando dos transacciones. Ella vendió 12,438 acciones comunes a un precio promedio ponderado de 51,94–51,95 dólares, generando aproximadamente 0,65 millones de dólares en ingresos. Ese mismo día recibió 26,620 unidades restringidas de acciones (RSU) que se convertirán una a una en acciones de EQT, con un periodo de adquisición en tres partes iguales anuales a partir de un año después de la concesión. Tras la venta y la concesión, su propiedad directa aumentó a 39,917 acciones, un incremento neto de 14,182 acciones (aproximadamente 55%). La nota sobre la venta de acciones indica que los desgloses completos de precios están disponibles a solicitud y que los totales incluyen dividendos acumulados. No se reportaron valores derivados, opciones u otros instrumentos. Aunque la venta por parte de un insider puede verse negativamente, el premio simultáneo y mayor de RSU resulta en un aumento general en la propiedad, mitigando preocupaciones sobre señales. La presentación no contiene actualizaciones financieras o estratégicas a nivel de la empresa.

2025년 7월 25일, EQT Corp의 EVP Upstream인 Sarah Fenton은 두 건의 거래를 공개하는 Form 4를 제출했습니다. 그녀는 12,438주의 보통주를 가중평균 가격 $51.94–$51.95에 매도하여 약 65만 달러의 수익을 창출했습니다. 같은 날 그녀는 26,620개의 제한 주식 단위(RSU)를 받았으며, 이는 1대1로 EQT 주식으로 전환되며, 1년 후부터 3년에 걸쳐 동일한 비율로 권리가 부여됩니다. 매도와 수령 이후 그녀의 직접 보유 주식은 39,917주로 증가하여 순증가분은 14,182주(약 55%)입니다. 주식 매도 주석에는 가격 세부 내역이 요청 시 제공되며, 총액에는 누적 배당금이 포함되어 있다고 명시되어 있습니다. 파생 증권, 옵션 또는 기타 금융 상품은 보고되지 않았습니다. 내부자의 매도는 부정적으로 해석될 수 있으나, 동시에 이루어진 더 큰 RSU 수령으로 전체 보유 지분이 증가해 신호에 대한 우려를 완화합니다. 제출 문서에는 회사 차원의 재무 또는 전략적 업데이트는 포함되어 있지 않습니다.

Le 25 juillet 2025, Sarah Fenton, EVP Upstream d'EQT Corp, a déposé un formulaire 4 dévoilant deux transactions. Elle a vendu 12 438 actions ordinaires à un prix moyen pondéré de 51,94–51,95 dollars, générant environ 0,65 million de dollars de produit. Le même jour, elle a reçu 26 620 unités d'actions restreintes (RSU) qui se convertiront en actions EQT à raison d'une pour une, avec une acquisition en trois tranches annuelles égales commençant un an après l'attribution. Après la vente et l'attribution, sa détention directe a augmenté à 39 917 actions, soit une hausse nette de 14 182 actions (environ 55 %). La note de bas de page sur la vente d'actions indique que des détails complets sur les prix sont disponibles sur demande et que les totaux incluent les dividendes accumulés. Aucun titre dérivé, option ou autre instrument n'a été déclaré. Bien que la vente par un initié puisse être perçue négativement, l'attribution simultanée et plus importante de RSU entraîne une augmentation globale de la participation, atténuant ainsi les inquiétudes liées au signal. Le dépôt ne contient aucune mise à jour financière ou stratégique au niveau de l'entreprise.

Am 25. Juli 2025 reichte Sarah Fenton, EVP Upstream von EQT Corp, ein Formular 4 ein, das zwei Transaktionen offenlegt. Sie verkaufte 12.438 Stammaktien zu einem gewichteten Durchschnittspreis von 51,94–51,95 USD und erzielte damit rund 0,65 Millionen USD Erlös. Am selben Tag erhielt sie 26.620 Restricted Stock Units (RSUs), die eins zu eins in EQT-Aktien umgewandelt werden und in drei gleichen jährlichen Tranchen ab einem Jahr nach der Gewährung vesten. Nach Verkauf und Gewährung stieg ihr direkter Besitz auf 39.917 Aktien, ein Nettostieg von 14.182 Aktien (ca. 55 %). Die Fußnote zum Aktienverkauf weist darauf hin, dass vollständige Preisaufschlüsselungen auf Anfrage verfügbar sind und dass die Gesamtzahlen aufgelaufene Dividenden enthalten. Es wurden keine Derivate, Optionen oder andere Instrumente gemeldet. Obwohl Insider-Verkäufe negativ gesehen werden können, führt die gleichzeitig größere RSU-Zuteilung zu einer Gesamtsteigerung des Besitzes, was Signalisierungsbedenken mildert. Die Einreichung enthält keine finanzielle oder strategische Unternehmensaktualisierung.


As filed with the Securities and Exchange Commission on July 28, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
LUMINAR TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Delaware83-1804317
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification No.)
2603 Discovery Drive, Suite 100
Orlando, Florida 32826
(Address of Principal Executive Offices) (Zip Code)
Non-Plan Inducement Restricted Stock Unit Award – Time-Based Vesting
Non-Plan Inducement Restricted Stock Unit Award – Fully Vested
Non-Plan Inducement Restricted Stock Unit Award – Performance-Based Vesting
(Full title of the plan)
Paul Ricci
Chief Executive Officer
2603 Discovery Drive, Suite 100
Orlando, Florida 32826
Telephone: (800) 532-2417
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)
Copies to:
Daniel S. Kim, Esq.
Mitchell Zuklie, Esq.
William L. Hughes, Esq.
Orrick, Herrington & Sutcliffe LLP
631 Wilshire Boulevard
Santa Monica, California 90401
Tel: (301) 633-2800
 
Alexander Fishkin, Esq.
Chief Legal Officer
2603 Discovery Drive, Suite 100
Orlando, Florida 32826
Telephone: (800) 532-2417
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.   



EXPLANATORY NOTE
This Registration Statement on Form S–8 (“Registration Statement”) is being filed by Luminar Technologies, Inc. (the “Registrant”) for the purpose of registering an aggregate of 2,109,546 shares of Class A common stock, par value $0.0001 per share, of the Registrant (the “Class A Common Stock”), issuable pursuant to inducement awards consisting of 820,379 restricted stock units subject to time-based vesting, 468,788 restricted stock units that will be fully vested upon grant, and up to 820,379 restricted stock units subject to performance-based vesting (collectively, the “Inducement Awards”), to be granted to Paul Ricci pursuant to inducement award agreements as inducement for acceptance of employment with the Registrant as Chief Executive Officer. The Inducement Awards will be granted outside of the Registrant’s Amended and Restated 2020 Equity Incentive Plan as inducement material to Mr. Ricci’s entering into his employment with the Registrant in accordance with Nasdaq Listing Rule 5635(c)(4).
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information required by Part I of Form S-8 is omitted from this filing in accordance with Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the instructions to Form S-8. The documents containing the information specified in Part I will be sent or given to the participant in the Inducement Awards covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424. These documents, and the documents incorporated by reference herein pursuant to Item 3 of Part II hereof, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have been filed by the Registrant with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are hereby incorporated by reference in this Registration Statement:
(a) The Registrant’s Annual Report on Form 10-K (File No. 001-38791) for the fiscal year ended December 31, 2024 filed on March 28, 2025, as amended by Form 10-K/A filed on April 30, 2025;
(b) The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 filed on May 20, 2025;
(c) The Registrant’s Current Reports on Form 8-K filed on March 24 2025, March 28, 2025 (amending the Current Report filed on March 24, 2025), April 1, 2025, May 15, 2025, May 15, 2025, May 21, 2025, May 22, 2025, May 23, 2025, May 27, 2025 (amending a Current Report filed on May 15, 2025) and July 8, 2025; and
(d) The description of the Class A Common Stock of the Registrant contained in the Registrant’s Registration Statement on Form 8-A (No. 001-38791) filed with the Commission on January 31, 2019, including any other amendments or reports filed for the purpose of updating such description (including the “Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934” included as Exhibit 4.4 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 28, 2025).
All documents filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (excluding any portions thereof furnished by the Registrant, including but not limited to



information furnished under Item 2.02 and Item 7.01 of Form 8-K and any exhibits furnished on such form that relate to such items and any certification required by 18 U.S.C. § 1350) after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, are deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the respective dates of filing of such documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Orrick, Herrington & Sutcliffe LLP (“Orrick”) and certain attorneys within Orrick own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of the Registrant’s Class A common stock.
Item 6. Indemnification of Directors and Officers.
Section 145 of the Delaware General Corporation Law (the “DGCL”) provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent to the corporation. The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise.
The Registrant’s restated certificate of incorporation and the Registrant’s restated bylaws provide in effect that, subject to certain limited exceptions, they may indemnify their directors and officers to the extent authorized and permitted by the DGCL. The Registrant also maintain policies to insure its directors and officers, subject to the limits of the policies, against certain losses arising from any claims made against them by reason of being or having been such directors or officers. In addition, the Registrant has entered into contracts with certain directors and officers of the Registrant, providing for indemnification of such persons by the Registrant to the full extent authorized or permitted by law, subject to certain limited exceptions.
Pursuant to Section 102(b)(7) of the DGCL, the Registrant’s restated certificate of incorporation provides that, to the fullest extent permitted by the DGCL, a director or officer of the Registrant shall not be personally liable to the Registrant or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability (i) for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for any transaction from which the director or officer derived an improper personal benefit, (v) for directors, for unlawful payments of dividends or unlawful stock repurchases, redemptions or other distributions, and (iv) for officers, in any action by or in right of the Company.
The Registrant’s restated certificate of incorporation provides that, to the fullest extent permitted by the DGCL, a director or officer shall not be liable to the Registrant or their stockholders for monetary damages for breach of fiduciary duty as a director or officer.
Item 7. Exemption from Registration Claimed.
Not applicable.




Item 8.     Exhibits.
The following documents are filed as exhibits to this Registration Statement.
Incorporated by Reference
Exhibit
Number
Description of ExhibitFormFile No.
Exhibit/Appendix
Filing DateFiled
Herewith
5.1
Opinion of Orrick, Herrington & Sutcliffe LLP.
X
23.1
Consent of Independent Registered Public Accounting Firm.
X
23.2
Consent of Orrick, Herrington & Sutcliffe LLP (included in Exhibit 5.1).
X
24.1
Power of Attorney (included in the signature page to this Registration Statement).
X
99.1
Form of Notice of Restricted Stock Unit Award and Agreement – Time-Based Vesting.
X
99.2
Form of Notice of Restricted Stock Unit Award and Agreement – Fully Vested.
X
99.3
Form of Notice of Restricted Stock Unit Award and Agreement – Performance-Based Vesting.
X
107
Filing Fee Table.
X
Item 9. Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.



(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b) The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.





SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Orlando, Florida, on July 28, 2025.
LUMINAR TECHNOLOGIES, INC.
By:
/s/ Thomas J. Fennimore
Thomas J. Fennimore
Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Paul Ricci, Alexander Fishkin and Thomas J. Fennimore, and each of them, as his or her true and lawful attorney-in-fact and agent with the full power of substitution, for him or her, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments to this Registration Statement on Form S-8), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons on behalf of the Registrant in the capacities and on the dates indicated:
SignatureTitleDate
/s/ Paul Ricci
Chief Executive Officer, Director
July 28, 2025
Paul Ricci
(Principal Executive Officer)
/s/ Thomas J. FennimoreChief Financial Officer
July 28, 2025
Thomas J. Fennimore
(Principal Financial and Accounting Officer)
/s/ Alec E. GoresDirector
July 28, 2025
Alec E. Gores
/s/ Mary Lou Jepsen, PhDDirector
July 28, 2025
Mary Lou Jepsen, PhD
/s/ Shaun Maguire, PhDDirector
July 28, 2025
Shaun Maguire, PhD
/s/ Katharine A. MartinDirector
July 28, 2025
Katharine A. Martin

Director

Austin Russell
/s/ Dominick Schiano
Director
July 28, 2025
Dominick Schiano
/s/ Matthew J. Simoncini
Director
July 28, 2025
Matthew J. Simoncini
/s/ Daniel D. TempestaDirector
July 28, 2025
Daniel D. Tempesta

Luminar Technologies Inc

NASDAQ:LAZR

LAZR Rankings

LAZR Latest News

LAZR Latest SEC Filings

LAZR Stock Data

178.80M
50.23M
5.89%
28.39%
12.28%
Auto Parts
Motor Vehicle Parts & Accessories
Link
United States
ORLANDO